Evidence map›Paper›PMID 26919057›Full record

ArticleJournal of affective disorders2016

OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding.

Christopher Pittenger, Thomas G Adams, Jean-Dominique Gallezot, Michael J Crowley, Nabeel Nabulsi, James Ropchan, Hong Gao, Stephen A Kichuk, Ryan Simpson, Eileen Billingslea and 5 more

Open access · greenAbstract read
In one paragraph

Article in Journal of affective disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Sensorimotor circuit connectivity as a candidate biomarker for responsiveness to sertraline in obsessive-compulsive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Integrating brainstem and cortical functional architectures.bioRxiv : the preprint server for biology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Christopher PittengerDepartment of Psychiatry, Yale University School of Medicine, USA; Department of Psychology, Yale University School of Medicine, USA; Child Study Center, Yale University School of Medicine, USA; Interdepartmental Neuroscience Program, Yale University School of Medicine, USA. Electronic address: Christopher.pittenger@yale.edu.
Thomas G AdamsDepartment of Psychiatry, Yale University School of Medicine, USA.
Jean-Dominique GallezotDepartment of Diagnostic Radiology, Yale University School of Medicine, USA; Yale PET Center, Yale University School of Medicine, USA.
Michael J CrowleyDepartment of Psychology, Yale University School of Medicine, USA.
Nabeel NabulsiDepartment of Diagnostic Radiology, Yale University School of Medicine, USA; Yale PET Center, Yale University School of Medicine, USA.
James RopchanYale PET Center, Yale University School of Medicine, USA.
Hong GaoYale PET Center, Yale University School of Medicine, USA.
Stephen A KichukDepartment of Psychiatry, Yale University School of Medicine, USA.
Ryan SimpsonDepartment of Psychiatry, Yale University School of Medicine, USA.
Eileen BillingsleaDepartment of Psychiatry, Yale University School of Medicine, USA.
Jonas HannestadDepartment of Psychiatry, Yale University School of Medicine, USA.
Michael BlochDepartment of Psychiatry, Yale University School of Medicine, USA; Child Study Center, Yale University School of Medicine, USA.
Linda MayesDepartment of Psychology, Yale University School of Medicine, USA; Child Study Center, Yale University School of Medicine, USA.
Zubin BhagwagarDepartment of Psychiatry, Yale University School of Medicine, USA.
Richard E CarsonDepartment of Diagnostic Radiology, Yale University School of Medicine, USA; Department of Biomedical Engineering, Yale University School of Medicine, USA; Yale PET Center, Yale University School of Medicine, USA.
Yale University · USYale Cancer Center · USUniversity School · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
Research Training in Functional Disability InterventionsT32MH062994 · NIMH · YALE UNIVERSITY · PI BELL, MORRIS D. · 2002 to 2017
$3.0M
CREB and the molecular underpinnings of habit learningK08MH081190 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2008 to 2012
$897k
5-HT1B receptor function in OCDR21MH090555 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2011 to 2012
$389k
NCATS NIH HHS UL1 TR000142NCATS NIH HHS UL1TR000142NCATS NIH HHS UL1 TR001863NIMH NIH HHS K08 MH081190NIMH NIH HHS K08MH081190NIMH NIH HHS L30 MH111037NIMH NIH HHS R21 MH090555NIMH NIH HHS R21MH090555NIMH NIH HHS T32 MH062994NIMH NIH HHS T32MH062994
6 · The paper itself

Abstract

Obsessive-compulsive disorder (OCD) is characterized by impaired sensorimotor gating, as measured using prepulse inhibition (PPI). This effect may be related to abnormalities in the serotonin (5-HT) system. 5-HT1B agonists can impair PPI, produce OCD-like behaviors in animals, and exacerbate OCD symptoms in humans. We measured 5-HT1B receptor availability using (11)C-P943 positron emission tomography (PET) in unmedicated, non-depressed OCD patients (n=12) and matched healthy controls (HC; n=12). Usable PPI data were obtained from 20 of these subjects (10 from each group). There were no significant main effects of OCD diagnosis on 5-HT1B receptor availability ((11)C-P943 BPND); however, the relationship between PPI and (11)C-P943 BPND differed dramatically and significantly between groups. 5-HT1B receptor availability in the basal ganglia and thalamus correlated positively with PPI in controls; these correlations were lost or even reversed in the OCD group. In cortical regions there were no significant correlations with PPI in controls, but widespread positive correlations in OCD patients. Positive correlations between 5-HT1B receptor availability and PPI were consistent across diagnostic groups only in two structures, the orbitofrontal cortex and the amygdala. Differential associations of 5-HT1B receptor availability with PPI in patients suggest functionally important alterations in the serotonergic regulation of cortical/subcortical balance in OCD.

Indexed as

Sensory GatingAdultAnimalsBasal GangliaCase-Control StudiesFemaleHumansInhibition, PsychologicalMaleObsessive-Compulsive DisorderPositron-Emission TomographyPrefrontal CortexReceptor, Serotonin, 5-HT1BSerotonin 5-HT1 Receptor AgonistsThalamusReceptor, Serotonin, 5-HT1BSerotonin 5-HT1 Receptor Agonists

Identifiers

PMID26919057
PMCPMC4808438
OpenAlexW2255345601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.